Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Stemtech's shares outstanding was 2.96B at Sep 30, 2026. For fiscal 2025 it was 170M, up 43.1% from the year before. Over ten years it grew 31.9% a year on average. The highest annual figure on record is 170M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 170M | +43.1% |
| FY2024 | Dec 31, 2024 | 119M | +42.2% |
| FY2023 | Dec 31, 2023 | 83M | +81.4% |
| FY2022 | Dec 31, 2022 | 46M | +30.3% |
| FY2021 | Dec 31, 2021 | 35M | +227.0% |
| FY2019 | Aug 31, 2019 | 11M | 0.0% |
| FY2018 | Aug 31, 2018 | 11M | 0.0% |
| FY2017 | Aug 31, 2017 | 11M | 0.0% |
| FY2016 | Aug 31, 2016 | 11M | 0.0% |
| FY2015 | Aug 31, 2015 | 11M | +1.2% |
| FY2014 | Aug 31, 2014 | 11M | +12.4% |
| FY2013 | Aug 31, 2013 | 10M | 0.0% |
| FY2012 | Aug 31, 2012 | 10M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | 2.96B | +1873.4% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 2.08B | +1358.4% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 812M | +584.2% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 229M | +74.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 150M | +24.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 142M | +22.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 119M | +42.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 131M | +24.5% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 121M | +19.9% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 117M | +27.2% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 83M | +43.2% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 105M | +114.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 101M | +120.6% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 92M | +105.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 58M | +30.5% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 49M | +354.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 46M | +30.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 45M | +314.0% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 45M | +313.8% |
| Q3 FY2021CQ3 2020 | May 31, 2021 | 11M | 0.0% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 35M | +223.4% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | 11M | 0.0% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | 11M | 0.0% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | 11M | 0.0% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | 11M | 0.0% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | 11M | 0.0% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | 11M | 0.0% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | 11M | 0.0% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | 11M | 0.0% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | 11M | 0.0% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | 11M | 0.0% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | 11M | 0.0% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | 11M | 0.0% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | 11M | 0.0% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | 11M | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | 11M | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | 11M | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | 11M | – |
See a number that looks wrong?